Jacqueline V. Aredo

ORCID: 0000-0003-0559-3565 · 5 papers in corpus
rct 2026
EClinicalMedicine ·doi:10.1016/j.eclinm.2025.103740

BACKGROUND: Chronic pelvic pain affects one in four women. Botulinum toxin, approved for chronic migraine and cervical dystonia pain, is an emerging treatment for other pain conditions. We evaluated intramuscular pelvic floor botulinum toxi…

other 2024
Toxins ·doi:10.3390/toxins16050216

Botulinum toxin (BoNT) injection can safely be done as an office-based procedure, but can be painful itself, especially when injecting pelvic floor muscles to treat chronic pelvic pain (CPP). Mindfulness interventions may reduce procedure-a…

2021
·doi:10.1016/j.fertnstert.2021.07.148
observational 2020
European journal of pain (London, England) ·doi:10.1002/ejp.1713

BACKGROUND: Chronic pelvic pain persists in some women with endometriosis even after lesion removal and optimized hormonal treatment. OBJECTIVE: Characterize the presence and distribution of pain, myofascial dysfunction and sensitisation b…

review 2017
Seminars in reproductive medicine ·doi:10.1055/s-0036-1597123

Chronic pelvic pain is a frustrating symptom for patients with endometriosis and is frequently refractory to hormonal and surgical management. While these therapies target ectopic endometrial lesions, they do not directly address pain due t…